ViiV Healthcare ULC v. Canada (Health), 2020 FC 756
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Federal Court (Canada) |
| Citation | 2020 FC 756 |
| Date | 10 July 2020 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
16 practice notes
-
Canada (Health) v. Glaxosmithkline Biologicals S.A., 2021 FCA 71
...wish to note that the present case may be quite different from the one before the Federal Court in ViiV Healthcare ULC v. Canada (Health), 2020 FC 756, which GSK relies on. In that case, it appears that the Minister failed to grapple with quite specific submissions made before her on the is......
-
Federal Court Finds Minister Of Health's Refusal Of BELSOMRA CSP Unreasonable, Remits For Redetermination
...set aside, and Merck's CSP application was remitted for redetermination. This decision, along with ViiV Healthcare ULC v. Canada (Health) 2020 FC 756 [JULUCA] and Canada (Health) v. GlaxoSmithKline Biologicals S.A., 2021 FCA 71; rev'g 2020 FC 397 [SHINGRIX], emphasizes the importance of the......
-
Federal Court Finds Minister Of Health's Refusal Of BELSOMRA CSP Unreasonable, Remits For Redetermination
...set aside, and Merck's CSP application was remitted for redetermination. This decision, along with ViiV Healthcare ULC v. Canada (Health) 2020 FC 756 [JULUCA] and Canada (Health) v. GlaxoSmithKline Biologicals S.A., 2021 FCA 71; rev'g 2020 FC 397 [SHINGRIX], emphasizes the importance of the......
-
Pharma: A Year In Review Through The Lens Of Our Trading Partner To The South
...should be noted that the FCA allowed an appeal and restored the Minster's decision: 2021 FCA 71; ViiV Healthcare ULC v. Canada (Health), 2020 FC 756; Merck Canada Inc. v. Canada (Health), 2021 FC 2. See Alexion Pharmaceuticals v. Canada (Attorney General), 2021 FCA 157. The Attorney General......
Request a trial to view additional results
1 cases
-
Canada (Health) v. Glaxosmithkline Biologicals S.A., 2021 FCA 71
...wish to note that the present case may be quite different from the one before the Federal Court in ViiV Healthcare ULC v. Canada (Health), 2020 FC 756, which GSK relies on. In that case, it appears that the Minister failed to grapple with quite specific submissions made before her on the is......
15 firm's commentaries
-
Federal Court Finds Minister Of Health's Refusal Of BELSOMRA CSP Unreasonable, Remits For Redetermination
...set aside, and Merck's CSP application was remitted for redetermination. This decision, along with ViiV Healthcare ULC v. Canada (Health) 2020 FC 756 [JULUCA] and Canada (Health) v. GlaxoSmithKline Biologicals S.A., 2021 FCA 71; rev'g 2020 FC 397 [SHINGRIX], emphasizes the importance of the......
-
Federal Court Finds Minister Of Health's Refusal Of BELSOMRA CSP Unreasonable, Remits For Redetermination
...set aside, and Merck's CSP application was remitted for redetermination. This decision, along with ViiV Healthcare ULC v. Canada (Health) 2020 FC 756 [JULUCA] and Canada (Health) v. GlaxoSmithKline Biologicals S.A., 2021 FCA 71; rev'g 2020 FC 397 [SHINGRIX], emphasizes the importance of the......
-
Pharma: A Year In Review Through The Lens Of Our Trading Partner To The South
...should be noted that the FCA allowed an appeal and restored the Minster's decision: 2021 FCA 71; ViiV Healthcare ULC v. Canada (Health), 2020 FC 756; Merck Canada Inc. v. Canada (Health), 2021 FC 2. See Alexion Pharmaceuticals v. Canada (Attorney General), 2021 FCA 157. The Attorney General......
-
Pharma: A Year In Review Through The Lens Of Our Trading Partner To The South
...should be noted that the FCA allowed an appeal and restored the Minster's decision: 2021 FCA 71; ViiV Healthcare ULC v. Canada (Health), 2020 FC 756; Merck Canada Inc. v. Canada (Health), 2021 FC 2. See Alexion Pharmaceuticals v. Canada (Attorney General), 2021 FCA 157. The Attorney General......
Request a trial to view additional results